300 Pages of Emails Leave No Doubt: Fauci, NIH Knew Early on of Injuries, Deaths After COVID Shots

Originally published on 16 th May 2024

According to documents obtained by Children’s Health Defense, reports of injuries and deaths following COVID-19 vaccines — including a child injured by the Pfizer vaccine during a clinical trial and a fatal vaccine-induced case of myocarditis — reached NIH researchers, Dr. Anthony Fauci and others in 2021 and 2022.

Several adverse event reports from people injured by the COVID-19 vaccines reached National Institutes of Health (NIH) researchers in 2021 and 2022 — including a report of a child injured by the Pfizer-BioNTech vaccine during a clinical trial, according to documents obtained by Children’s Health Defense (CHD).

The documents also include reports of vaccine-injured people who were suicidal and emails sent to government officials — including Dr. Anthony Fauci — by a COVID-19 vaccine injury victim frustrated with the Countermeasures Injury Compensation Board’s (CICP) slow pace of responding to their vaccine injury claims.

As reports of vaccine injuries came in, the agency advised one injured person that it was “not prudent” to get a second dose.

Some researchers cited a lack of knowledge about vaccine injuries due to the rapid speed at which they were developed.

The 300-page batch of documents released to CHD on April 21 contains emails between the NIH and people reporting COVID-19 vaccine injuries. CHD requested the documents via a Freedom of Information Act (FOIA) request in November 2022.

On April 12, 2023, CHD sued the NIH to obtain the records after the NIH did not respond to the request.

In an October 2023 settlement, the NIH agreed to produce up to 7,500 pages of documents at a rate of 300 pages per month. This month’s batch also revealed that Fauci and U.S. Food and Drug Administration (FDA) officials knew of serious COVID-19 vaccine adverse events as early as December 2020.

‘No doubt in my mind that the vaccine caused’ girl’s injuries

In emails sent to NIH researchers Farinaz Safavi, M.D., Ph.D., Dr. Avindra Nath and Amanda Wiebold starting May 24, 2021 (pages 237-243), the parents of a girl injured during the Pfizer-BioNTech COVID-19 vaccine trial detailed their daughter’s condition.

Symptoms initially included “severe muscle/nerve pain, painful electric shocks down her neck and spine which caused her to walk hunched over, severe chest pain that felt like her heart was being pulled out,” pain in her toes, a fever and “severe abdominal pain.”

According to the email, the symptoms “persisted” and new symptoms developed, including “the inability to swallow food or liquids,” “unexplained painful cysts on her vagina and then her head,” “erratic blood pressure, and heart rate, memory loss, brain fog, verbal and motor tics, fainting/seizures (10+ a day), loss of feeling from the waist down then paralysis of her legs, inability to walk,” tinnitus, vision problems and others.

These injuries led to nine ER visits and three hospital admissions. According to the email, the girl developed “medical PTSD” from “this experience with doctors, especially in the ER and Pfizer Vaccine Trial, doubting her and treating her like a mental patient.”

“There is no doubt in my mind that the vaccine caused this,” the email read.

In a May 25, 2021, response, Nath said, “It is hard to make a diagnosis over emails” but “We have certainly heard of a lot of cases of neurological complications form [sic] the vaccine,” offering to speak to the girl’s neurologist.

On May 26, 2021, the girl’s parents said specialists they visited had “an unconscious bias” and, “from the beginning” at the hospital that hosted the trial, “no one was even willing to talk about the vaccine as the trigger for this.”

In a May 27, 2021 email, the girl’s parents added that inpatient rehabilitation doctors “were not willing” to speak with Nath. “They are unwilling to look any further into this because then they would have to admit the vaccine caused her reaction.” But no further reply from Nath or other NIH officials appears in the documents.

‘It would not be prudent to receive the second dose’

In a Jan. 22, 2021, email (pages 162-163), a vaccine-injured person contacted Dr. Alkis Togias, branch chief of Allergy, Asthma, and Airway Biology at the National Institute of Allergy and Infectious Diseases, after having “ended up in the ER” following an anaphylactic reaction after the first dose of the Pfizer-BioNTech COVID-19 vaccine.

“I had never had severe reactions to anything, until the last year, when I have had three,” the individual wrote, asking Togias if it was safe to receive the second dose.

In his Jan. 23, 2021, reply, Togias said, “It would be very hard … to offer an opinion as to whether you experienced a true allergic reaction.” “If what you experienced was a true allergic reaction, it would not be prudent to receive the second dose.”

In a March 24, 2021, follow-up email (page 175), Togias admitted “There is no study that I am aware of that has carefully followed people who had a reaction to the first shot and received the second shot. As a result of this lack of knowledge, I do not think that anybody can advise you with major certainty as to whether to proceed with the 2nd dose.”

“If you fulfill the criteria for a severe allergic reaction as defined in the CDC guideline … you should not be receiving the second dose,” Togias added. He also noted that “the lack of clear answers to your questions reflects our lack of knowledge,” which he said “is not surprising given the speed at which these vaccines came out.”

In another instance, someone contacted Togias on Feb. 24, 2021 (pages 289-290), informing him of “a pretty scary reaction” to the first dose of the Moderna COVID-19 vaccine “within one hour of getting it.”

“This was a frightening occurrence, and I suspect it was a mild anaphylactic shock,” the individual wrote, noting that they had “never felt anything like this.” The person asked for “any advice on whether I should get the second shot in a month.”

In his Feb. 24, 2021, reply, Togias said it was hard to say “whether it was an allergic reaction or not” but noted that “Both the Moderna and the Pfizer vaccines have induced allergic reactions” and suggested it might not be a good idea to get a second dose.

“The most important decision is, of course, whether you should receive your second dose or not,” Togias wrote, recommending the patient consult with an allergist and report their reaction to the Vaccine Adverse Event Reporting System (VAERS).

NIH officials gave mixed messages about VAERS in other emails. Notably, in a March 24, 2021, email (page 175), Togias said “VAERS is based on self-reporting and it misses a tremendous amount of information that would have been so helpful to everybody.”

But, in a June 13, 2021, email (page 257), Nath wrote, in response to whether 110 VAERS reports of transverse myelitis after COVID-19 vaccination constitute a safety signal, that “the reliability of the VAERS database is poor since anyone can enter the information and there may even be duplication of entries.”

‘My life as I knew it was gone’

The documents also show that vaccine-injured individuals contacted NIH researchers before January 2021.

In a Dec. 25, 2020, email (page 167), a person injured after getting the Pfizer-BioNTech vaccine said that, within 30 minutes, they felt “burning and tingling of my face, tightness at the base of my tongue, shortness of breath, heart racing, chest tightness and had a near syncopal event.” Symptoms, including facial swelling and hives, recurred the next day.

“I believe I am having a significant allergic reaction to the vaccine,” the person wrote, adding that they were “very nervous about receiving the second dose of the vaccine.”

In his Dec. 27, 2020, reply (page 166), Togias said he “can understand [the person’s] hesitancy for receiving the second dose” and that he was aware of such reactions to the Pfizer and Moderna vaccines.

The individual sent follow-up emails on Dec. 29, 2020, and Jan. 2, 2021 (page 165), reporting they were still ill, “really afraid” and “frightened,” reporting “tachycardia … chest tightness, anorexia,” and an opinion from a rheumatologist and immunologist, who believed they were experiencing “some time [sic] of immunological/neurological reaction.”

In a Jan. 3, 2021, reply, Togias suggested the patient file a VAERS report, but in replies on Jan. 3, the injured individual wrote that they filed reports “to VAERS, v safe [sic], Pfizer multiple times but have had no response from anyone.”

With no response from Togias, the individual sent a Feb. 10, 2021 (page 164), email, saying they were “very desperate,” “still very ill with neurological symptoms” and “completely incapacitated … with severe paresthesias in my face, tongue, chest wall, limbs,” asking Togias for “anyone … who might be able to help me in some way recover.”

In Togias’ Feb. 11, 2021, reply (page 164), he said that similar injuries “have been reported by other people; so the various agencies and the companies know about them” but that he was “not aware whether any research is being conducted to understand their nature.” No other responses appear in the documents that have been released.

Autopsy ‘concurred’ death caused by Pfizer booster shot

A person who lost their brother to a vaccine injury sent a Jan. 24, 2022, email (pages 139 and 184) to Togias, stating that an autopsy “concurred that his death was caused directly due to the Pfizer booster vaccine” as a result of “severe myocarditis.”

“Please give us answers and follow up to why this occurred,” the individual wrote. But in his Jan. 30, 2022, reply (page 184), Togias said myocarditis caused by COVID-19 vaccines is “rare” and “more commonly seen in young males,” adding that the victim “was in the very, very small group of people who lost their lives” and suggesting the filing of a VAERS report.

In an email exchange with Nath and Safavi (pages 9-12) beginning Jan. 9, 2022, an injured individual said they had emailed Safavi in April 2021 with no response and described “severe” injuries immediately after receiving the Moderna vaccine, including “cardiac issues” and “severe neurological issues.”

“At the twelve minute mark my life as I knew it was gone,” the patient wrote (page 11). In a response the same day, Nath wrote, “We are just as mystified as everyone else about these complications,” while in a Jan. 10, 2022, email (page 9), she said she has “absolutely no idea what might be causing your symptoms.”

But in a Jan. 10, 2022, reply, the injured person said they were “at the best research hospitals,” but doctors there were “waiting for direction from the FDA and NIH on what is going on as there has been no study that they know of as to why this is happening.”

“So many people are suffering and I’m talking people out of suicide on a weekly basis who are having the same reactions and can’t take it,” the individual wrote.

Fauci ignored complaint of CICP’s slow processing of vaccine injury claim

The emails of a person who developed myocarditis after receiving the Pfizer-BioNTech COVID-19 vaccine and who was frustrated with CICP’s slow processing of their vaccine injury report was also included in this month’s documents (pages 292-300).

According to the emails, CICP received this person’s report on Sept. 7, 2021, and confirmed receipt on Sept. 20, 2021 (page 299), but said, “The CICP cannot estimate when a decision may be made in you [sic] claim.” After two follow-up emails requesting an update, CICP said on Sept. 28, 2021 (page 297), “There is no new update for your claim.”

By Oct. 5, 2021, though, the injured individual wrote to CICP, “I’m done waiting! Your time is up!” and threatened to contact lawmakers. The individual ultimately reached out to Rep. James McGovern (D-Mass.) — and to Fauci, in an Oct. 20, 2021 email (page 292).

“I received myocarditis from the Pfizer vaccine [redacted] and spent 3 days in the hospital. It wasn’t fun. It was a wretched experience. I now have bills to pay.” This person noted that CICP only had eight people reviewing claims, calling this “simply unacceptable.”

“I’ve contacted the CICP, news organizations, and my local Senators and Congressman. Haven’t heard much of anything yet.” “I would love to hear from Dr Fauci or anyone at NIH with a response.” But no such response came.

Suggest a correction